Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CME vs GSK✓SelectedUSD · GSKCME vs GSK performance historyLatest closeAs of-2.45%11/17
Stock and ETF performance explorer

CME vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+69.8%
GSK return
+43.9%
Excess return
+25.8%
Maximum drawdown
-31.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.4%-2.3%-0.1%-2.1%
7D+0.8%-3.0%+3.8%+1.3%
30D+6.0%+0.4%+5.7%+5.9%
3M+16.9%-1.2%+18.0%+16.9%
6M+5.3%+0.9%+4.4%+4.9%
YTD+18.0%+4.0%+14.0%+16.3%
1Y+16.0%+7.3%+8.7%+13.7%
3Y+65.9%+57.1%+8.8%+48.7%
5Y+69.8%+43.0%+26.8%+47.7%
All+69.8%+43.9%+25.8%+47.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling